JPRN-UMIN000016738已完成未知
Zinc L-carnosine complex polaprezinc for pica and polydipsia - Zinc L-carnosine complex polaprezinc for pica and polydipsia
Department of Public Health and Environmental Medicine, The Jikei University School of Medicine0 个研究点目标入组 20 人开始时间: 2015年3月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Malignant tumor 2) Chronic renal failure (estimated glomerular filtration rate, eGFR <45) 3) Other severe diseases 4) Terminal phase of an illness 5) History of taking polaprezinc or other zinc supplementation
研究者
相似试验
已完成
不适用
Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitislcerative ColitisJPRN-UMIN000008967The Jikei University School of Medicine Division of Gastroenterology and Hepatology30
已完成
不适用
Polaprezinc (Zinc L-carnosine) in Infants With Gastroesophageal RefluxGastroesophageal Reflux (GER)InfantsNCT06678997University of Roma La Sapienza60
已完成
不适用
Effect of zinc carnosine and bovine colostrum, alone and in combination, on gut permeability following endurance exerciseGut/intestinal permeability in healthy and physically active sports peopleISRCTN51159138Aberystwyth University (UK)8
已完成
3 期
A clinical trial to study the effect of Zinc sulfate in reducing the incidence of diarrhea, acute respiratory tract infections and in promoting growth in infants of 6-11 months of age.CTRI/2010/091/001417Indian Council Of Medical Research220
已完成
2 期
The chelating effect of zinc in patients with Covid 19Condition 1: covid-19. Condition 2: covid-19. Condition 3: covid-19. Condition 4: covid-19.Coronavirus infection, unspecifiedDyspneaCoughPneumonia due to SARS-associated coronavirusB34.2R06.0J12.81IRCT20210913052453N1Asadabad University of Medical Sciences50